Thank you for subscribing!
Finfeed Archived May 07, 2021
A global regulatory framework for environmental, social and governance (ESG) investing is now urgently required, says Nigel Green the CEO of one of the world’s largest independent financial advisory and fintech organisations – deVere Group.
Finfeed Archived Feb 26, 2021
Elixir Energy (ASX: EXR)'s share price has been running the past two weeks and is now up to 22 cents. EXR made Mongolia’s first ever gas discovery and is now progressively unlocking a massive, clean burning, natural gas source in Mongolia.
Finfeed Archived Nov 18, 2020
The rally has stalled across Europe, pausing for breath after the huge gains of the past week that have been driven by positive vaccine news.
Finfeed Archived Oct 14, 2020
The ASX had a particularly strong run last week, but the winning streak appears to have come to an end with equities markets falling significantly across Europe and the US.
Get expert stock analysis direct in your inbox
Finfeed Archived Oct 06, 2020
Much of yesterday’s ASX gains were on the back of optimistic expectations regarding tonight’s budget which is expected to provide tax cuts, cash injections and stimulus packages for consumers and businesses.
Finfeed Archived Oct 02, 2020
US markets ended up higher overnight, with the Nasdaq leading the way, up 1.42% thanks to tech giants Netflix (+5.5%), Telsa (+4.5%), Amazon (+2.3%), Facebook (+1.8%), and Alphabet 1.5%.
Finfeed Archived Aug 31, 2020
To put things in perspective, the Dow Jones last traded around this level of February 21, a day on which the US recorded one new COVID-19 case.
Finfeed Archived Aug 28, 2020
After winning US approval to market a cheap, portable, rapid COVID-19 antigen test Abbott Laboratories jumped 7.8%.
Finfeed Archived Aug 21, 2020
The S&P 500 regained all of the losses it suffered in March, when the pandemic hit. It is up 16.8% over the past 12 months. The stocks that make up the S&P 500 are mostly those which are trying to change the world in light of COVID-19.
Finfeed Archived May 18, 2020
After a rollercoaster week, a 76 point gain was enough to drag the S&P/ASX 200 (XJO) back into the black. Overseas markets were generally less volatile on Friday, albeit not making the substantial gains. However, it could be argued that market stability is a better sign than the extreme highs and lows that have set the tone in recent months.
Finfeed Archived May 14, 2020
While the ASX dug itself out of a hole yesterday, it is unlikely that investors will brush off the news that US markets plunged more than 500 points overnight.
Finfeed Archived May 12, 2020
The S&P/ASX 200 finished up 1.3% to close at 5461 points on Monday. With mixed to negative leads coming from overseas last night some profit-taking would surprise.
Finfeed Archived May 08, 2020
Wall Street’s indexes climbed on Thursday, with the Nasdaq erasing losses for 2020, following a clutch of upbeat earnings reports led by PayPal.
Finfeed Archived May 01, 2020
According to many surveys conducted by the ASX, it is common to find around 50 per cent of adult Australians believe they are very knowledgeable or somewhat knowledgeable when it comes to investing in shares. Are they overestimating their abilities?
Finfeed Archived Apr 30, 2020
The ASX looks set for another strong performance today after the S&P/ASX 200 increased 1.5% on Wednesday. With good news all round, it is not surprising to see that the ASX SPI200 up 108, indicating the ASX is in for a good day.
Finfeed Archived Apr 16, 2020
Don’t be lured into the ‘Bear Market Trap’ and perceived honey pot of gains to be had just because the market has risen like a soufflé in the past few weeks.
Finfeed Archived Mar 25, 2020
While the Australian stock market responded positively to the strong lead from Wall Street after the Dow surged more than 2000 points or 11% overnight, the gains were nowhere near those experienced in the US.
Finfeed Archived Feb 27, 2020
The coming 12 months is shaping up as a watershed stage in the history of Oncosil Medical Ltd (ASX:OSL) as it flags the finalisation of commercialisation plans for its OncoSil™ device ahead of CE marking early in 2020.
Join Our Mailing List
